HeartPlace Mid-Cities EP
Bedford, Texas, United States
Doctor in Bedford, Texas
1305 Airport Fwy Suite 301, Bedford, TX 76021
About HeartPlace Mid-Cities EP
"HeartPlace Mid Cities Electrophysiology (EP) is conveniently located right off of Highway 183 in Bedford. We have a wonderful group of physicians ready to serve you. At HeartPlace Mid Cities Electrophysiology (EP), we specialize in electrophysiology cardiology (electrical/heart rhythms). We have a wide variety of diagnostic tools and evaluation methods to help cover all of your electrophysiology needs. Call us today for your appointment. We look forward to meeting you and starting your journey to a healthy heart."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at HeartPlace Mid-Cities EP
During the past decade, HeartPlace Mid-Cities EP conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
2014-08-18
2026-10-10
Active, not recruiting
450
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
2014-08-18
Recruiting
8,300
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
2014-08-18
2036-05-01
Recruiting
168
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
2015-07-13
2023-10-02
Active, not recruiting
300
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma
2015-09-10
2033-06-30
Recruiting
600
Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy
2015-04-29
2031-03-29
Active, not recruiting
415
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
2015-08-12
2025-12-31
Active, not recruiting
6,452
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at HeartPlace Mid-Cities EP
According to Clinical.Site data, the most researched conditions in "HeartPlace Mid-Cities EP" are
"Atrial Fibrillation" (1 trials), "Paroxysmal Atrial Fibrillation" (1 trials), "Primary Prevention of Sudden Cardiac Arrest" (1 trials) and "Secondary Prevention of Sudden Cardiac Arrest" (1 trials). Many other conditions were trialed in "HeartPlace Mid-Cities EP" in a lesser frequency.
Clinical Trials Intervention Types at HeartPlace Mid-Cities EP
Most popular intervention types in "HeartPlace Mid-Cities EP" are "Device" (3 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Boston Scientific Open Irrigated Ablation Catheters" (1 trials), "Market-approved OAC" (1 trials), "S-ICD System" (1 trials) and "WATCHMAN FLX Implant" (1 trials). Other intervention names were less common.
Clinical Trials Genders at HeartPlace Mid-Cities EP
The vast majority of trials in "HeartPlace Mid-Cities EP" are
3 trials for "All" genders.
Clinical Trials Status at HeartPlace Mid-Cities EP
Currently, there are NaN active trials in "HeartPlace Mid-Cities EP".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in HeartPlace Mid-Cities EP,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in HeartPlace Mid-Cities EP, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".